Paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) is characterized by a diffuse proliferation of cells, called paraimmunoblasts, normally located on the pseudoproliferation centers. Patients usually present with multiple lymphadenopathies and a rapid and aggressive progression of the disease. We report a case with paraimmunoblastic variant of SLL/CLL genetically well-characterized by conventional cytogenetics, comparative genomic hybridization (CGH), IgH/BCL-1, IgH/BCL-2, and p53 fluorescent in situ hybridization (FISH) probes and polymerase chain reaction (PCR) for detection of IgH/BCL-2 translocation. A complex karyotype was found, with p53 deletion confirmed by CGH and FISH; however, no translocations involving either BCL-2 or BCL-1 and the immunoglobulin heavy chain gene were identified. A literature review shows only 20 previously reported cases, 6 of which involve genetic studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/hupa.2002.129209 | DOI Listing |
Oncol Lett
August 2017
Department of Hematology, Soroka University Medical Center and Faculty of Health Sciences, Ben Gurion University of The Negev, Beer-Sheva 84101, Israel.
A 78-year-old male who presented with severe shortness of breath and bilateral nasal congestion was shown to exhibit ta mass localized in the nasopharynx. The tumor was diagnosed as an extramedullary plasmacytoma. Peripheral blood eosinophilia had been persistently noted in the preceding 12 years.
View Article and Find Full Text PDFHum Pathol
November 2002
Laboratori de Citogenètica i Biologia Molecular, Departament de Patologia, Escola de Citologia Hematològica Soledad Woessner-IMAS, Barcelona, Spain.
Paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) is characterized by a diffuse proliferation of cells, called paraimmunoblasts, normally located on the pseudoproliferation centers. Patients usually present with multiple lymphadenopathies and a rapid and aggressive progression of the disease. We report a case with paraimmunoblastic variant of SLL/CLL genetically well-characterized by conventional cytogenetics, comparative genomic hybridization (CGH), IgH/BCL-1, IgH/BCL-2, and p53 fluorescent in situ hybridization (FISH) probes and polymerase chain reaction (PCR) for detection of IgH/BCL-2 translocation.
View Article and Find Full Text PDFDiagn Mol Pathol
December 2001
Department of Clinical Pathology, Cleveland Clinic Foundation, Ohio 44195, USA.
Increasingly, molecular biologic techniques have become important in the diagnosis of non-Hodgkin lymphomas. In the differential diagnosis of lymphoma(s) of small lymphocytes (LSL), reliable detection of t(11;14) or t(14;18) would confirm the diagnosis of mantle cell lymphoma (MCL) or follicle center lymphoma (FCL), respectively. A total of 87 LSL cases (27 MCL, 39 FCL, 17 small lymphocytic lymphoma [SLL], 3 marginal zone lymphomas, and 1 paraimmunoblastic variant of SLL) were diagnosed by a combination of light microscopy, immunohistochemistry, and flow cytometric immunophenotyping.
View Article and Find Full Text PDFMod Pathol
January 1998
Department of Pathology, Saint Louis University Health Sciences Center, Missouri 63104, USA.
To evaluate the usefulness of polymerase chain reaction analysis of translocations involving the bcl-1 and bcl-2 genes in variants of CD5-positive B-cell lymphomas, we analyzed four cases classified as the paraimmunoblastic variant of small lymphocytic lymphoma. This neoplasm, originally identified as an aggressive, diffuse, B-lineage lymphoma related to small lymphocytic lymphoma, can be confused with variants of mantle cell lymphoma (an immunophenotypically and morphologically similar neoplasm). No translocations involving bcl-2 and the immunoglobulin heavy chain gene were identified; two cases had translocations involving the bcl-1 and the immunoglobulin heavy chain genes.
View Article and Find Full Text PDFAm J Surg Pathol
January 1998
Department of Pathology II, University of Leuven, Belgium.
According to the French-American-British (FAB) proposal on the classification of chronic lymphoid leukemia (CLL), the disorder can be subdivided into typical and atypical CLL. We recently demonstrated the prognostic significance of this subgrouping and based on these results we suggested that typical and atypical CLL represent two closely related, but different entities. These results prompted us to investigate 42 patients diagnosed with CLL based on the results of lymph node biopsy in order to identify the histologic counterpart of the CLL variants.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!